Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
featured

Journal Scan / Research · July 09, 2024

Adverse Event Comparison Between GLP-1 Receptor Agonists and Other Antiobesity Medications Following Bariatric Surgery

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery
Diabetes Obes Metab 2024 Jun 27;[EPub Ahead of Print], JM Samuels, KD Niswender, CL Roumie, MD Spann, CR Flynn, F Ye, J Blankush, R Irlmeier, LM Funk, MB Patel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading